|
|||||
|
|
Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study† |
|
| Authors: | Ramzi Dagher Lauren M. Long Elizabeth J. Read Susan F. Leitman Charles S. Carter Maria Tsokos Theresa J. Goletz Nilo Avila Jay A. Berzofsky Lee J. Helman Crystal L. Mackall |
| Abstract: | |
| Keywords: | immunotherapy tumor vaccine IL‐2 translocation Ewing sarcoma rhabdomyosarcoma |